On December 6, 2024, Stephen Riddick, a Director at Bowman Consulting Group Ltd (BWMN, Financial), sold 2,288 shares of the company. Following this transaction, the insider now owns 20,248 shares of the company. The details of this transaction can be found in the SEC Filing.
Bowman Consulting Group Ltd is a professional services firm delivering innovative engineering solutions to customers who own, develop, and maintain the built environment. The company provides a variety of services, including planning, engineering, surveying, environmental, and construction management.
The insider transaction history for Bowman Consulting Group Ltd indicates that there have been no insider buys over the past year, while there have been 31 insider sells during the same period. This recent sale by Stephen Riddick is part of this trend.
As of the transaction date, shares of Bowman Consulting Group Ltd were trading at $28.60 each, giving the stock a market cap of $496.793 million. The stock's GF Value is estimated at $29.32, resulting in a price-to-GF-Value ratio of 0.98. This suggests that the stock is fairly valued according to its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on three factors:
- Historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at.
- A GuruFocus adjustment factor based on the company’s past returns and growth.
- Future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
